Journal of Advanced Pharmaceutical Science And Technology

Journal of Advanced Pharmaceutical Science And Technology

Journal of Advanced Pharmaceutical Science And Technology – Aim And Scope

Open Access & Peer-Reviewed

Submit Manuscript

Aims & Scope

Journal of Advanced Pharmaceutical Science and Technology (JAPST) publishes research advancing drug formulation, delivery systems, pharmaceutical analysis, and manufacturing technologies that bridge laboratory innovation to scalable pharmaceutical applications.
Drug Formulation Delivery Systems Pharmaceutical Analysis Manufacturing Technology Pharmacokinetics Quality Control

Core Research Domains

Drug Formulation & Development

  • Formulation design and optimization
  • Dosage form development (tablets, capsules, injectables, transdermals)
  • Excipient selection and compatibility studies
  • Stability testing and shelf-life prediction
  • Scale-up and manufacturing process development
  • Quality by Design (QbD) approaches
Typical fit: Development of a sustained-release tablet formulation using novel polymer matrices with stability data across temperature and humidity conditions.

Drug Delivery Systems

  • Nanoparticle-based delivery (liposomes, polymeric nanoparticles, solid lipid nanoparticles)
  • Controlled and sustained release systems
  • Targeted drug delivery mechanisms
  • Transdermal and transmucosal delivery
  • Pulmonary and nasal delivery systems
  • Implantable and injectable depot systems
Typical fit: Characterization of PLGA nanoparticles for controlled release of a hydrophobic drug with in vitro release kinetics and cellular uptake studies.

Pharmaceutical Analysis

  • Analytical method development and validation
  • Chromatographic techniques (HPLC, UPLC, GC, LC-MS)
  • Spectroscopic methods (UV-Vis, IR, NMR)
  • Dissolution testing and bioanalytical methods
  • Impurity profiling and degradation studies
  • Process Analytical Technology (PAT)
Typical fit: Development and validation of a stability-indicating HPLC method for quantification of an API and its degradation products in pharmaceutical formulations.

Pharmacokinetics & Biopharmaceutics

  • ADME (Absorption, Distribution, Metabolism, Excretion) studies
  • Bioavailability and bioequivalence assessment
  • Pharmacokinetic modeling and simulation
  • Drug-drug interaction studies (mechanistic)
  • In vitro-in vivo correlation (IVIVC)
  • Permeability and solubility enhancement
Typical fit: Pharmacokinetic modeling of a novel formulation in animal models with correlation to in vitro dissolution profiles for IVIVC establishment.

Secondary Focus Areas

Pharmaceutical Materials Science

  • Polymers for pharmaceutical applications
  • Biomaterials and biocompatible materials
  • Crystallization and polymorphism
  • Particle engineering and size reduction
  • Material characterization techniques

Manufacturing & Process Technology

  • Continuous manufacturing processes
  • Pharmaceutical engineering principles
  • Granulation, coating, and drying technologies
  • Aseptic processing and sterile manufacturing
  • Equipment design and optimization

Quality Assurance & Regulatory Science

  • Quality control methodologies
  • GMP compliance and validation
  • Regulatory submission strategies
  • Risk assessment in pharmaceutical development
  • Pharmacopeial standards and testing

Computational Pharmaceutics

  • Molecular modeling for drug-excipient interactions
  • In silico prediction of drug properties
  • Machine learning for formulation optimization
  • Computational fluid dynamics in pharmaceutical processes
  • QSAR/QSPR modeling for pharmaceutics

Emerging & Cross-Disciplinary Areas

Selective Consideration - Additional Editorial Review

3D printing and additive manufacturing for personalized medicine
Artificial intelligence in formulation development
Microfluidics for pharmaceutical applications
Organ-on-chip models for drug absorption studies
Pharmaceutical biotechnology (protein formulation, biologics stability)
Green chemistry and sustainable pharmaceutical manufacturing
Note: Manuscripts in these areas undergo additional editorial assessment to ensure alignment with pharmaceutical science focus rather than clinical or purely biological applications.
📄

Article Types & Editorial Priorities

Priority 1
(Fast-Track)
Original Research Articles Systematic Reviews & Meta-Analyses Method Development & Validation Technical Notes
Priority 2
(Standard Review)
Short Communications Data Notes Perspectives & Commentaries Review Articles
Rarely Considered
Case Reports (unless exceptional formulation challenge) Opinion Pieces Letters to Editor

Editorial Standards & Requirements

Reporting Guidelines

  • CONSORT for formulation trials
  • PRISMA for systematic reviews
  • ARRIVE for animal pharmacokinetic studies
  • ICH guidelines for analytical validation
  • MIRIBEL for bioequivalence studies

Data & Reproducibility

  • Raw data deposition encouraged (Figshare, Dryad)
  • Detailed formulation compositions required
  • Statistical analysis methods fully described
  • Analytical method validation parameters
  • Reproducibility statements mandatory

Ethics & Compliance

  • IACUC approval for animal studies
  • IRB approval if human bioavailability data
  • Conflict of interest disclosure
  • Funding source transparency
  • GMP compliance for manufacturing studies

Preprint & Prior Publication

  • Preprints allowed (arXiv, ChemRxiv, bioRxiv)
  • Conference abstracts acceptable
  • No duplicate publication
  • Thesis chapters acceptable with disclosure
  • Must declare all prior dissemination

Ready to Submit?

If your research advances pharmaceutical formulation, delivery systems, analytical methods, or manufacturing technology with rigorous experimental design and reproducible data, we want to hear from you.

Submit Your Manuscript